Reasons to Hold HealthEquity Stock in Your Portfolio for Now

HealthEquity’s fiscal Q2 2027 revenue rose 7.6% to $350.7 million and adjusted EPS increased 14.8% year over year to $1.24, beating consensus by 4.2%; the company raised fiscal 2027 adjusted EBITDA guidance to $628-$636 million and revenue guidance to $1.411-$1.421 billion. HSA assets reached $37.9 billion, up 14%, while AI handled 85% of routine chat inquiries and supported lower service costs. Offsetting the growth outlook, shares were down 0.6% year to date, and the company faces a lawsuit and regulatory inquiries tied to a fiscal 2025 cybersecurity incident whose potential loss was not reasonably estimable.

Analysis

HQY’s setup is operationally constructive but not yet a clear estimate-revision trade. AI-driven service efficiency could expand margins if savings persist as automation moves into onboarding and claims; the key test is whether service costs per account fall without worsening client retention or service outcomes. Meanwhile, growth in investment balances is not equivalent to recurring operating growth: market appreciation and transfers from cash contributed, so separate net contributions, account growth and custodial revenue from market effects. If custodial economics are sensitive to interest rates, falling rates could offset some balance growth; verify revenue sensitivity and cash yields before underwriting the outlook.

The mismatch between higher EBITDA guidance and unchanged EPS guidance/consensus makes near-term rerating less certain. Cyber exposure is a distinct, unresolved overhang: the disclosed matter concerns a business-partner user account, not evidence of a broad company-wide breach, but adverse litigation or regulatory developments could affect client confidence and service costs. Over 1–3 months, watch the next results for organic HSA contribution growth, custodial revenue, service cost per account and guidance revisions. Over 6–18 months, successful workflow automation could support operating leverage; execution or security failures could impair that thesis. Benefits-platform competitors, including WEX and bank/benefits administrators, may gain if clients prioritize perceived security or service reliability. With no valuation or relative-performance data sufficient to establish upside, the risk/reward favors measured exposure rather than chasing an efficiency narrative.

Key Decisions for Investors

• Keep HQY at a measured/hold-sized exposure; consider adding only after results confirm that custodial revenue and net HSA contributions—not just investment-market gains or cash transfers—are supporting growth.
• Treat further automation as a catalyst to monitor, not yet as a standalone margin forecast. Reassess if service cost per account stops declining, client/service indicators weaken, or management fails to extend automation into back-office workflows.
• Maintain a cybersecurity/legal risk alert. Revisit the thesis on material regulatory or litigation developments, evidence of broader client impact, or signs of elevated remediation costs; the disclosed incident alone does not establish a company-wide breach.
• Do not force a sector pair from this evidence. Before comparing HQY with WEX or other administrators, verify relative valuation, custodial revenue rate sensitivity, client retention and security exposure.